Dexcom (Nasdaq:DXCM) today filed an SEC form to announce that Chair and CEO Kevin Sayer is taking a temporary medical leave ...

Modular Medical (Nasdaq:MODD) announced that it received Institutional Review Board (IRB) approval to study its ...

Roche announced today that it received CE mark for the integration of its Accu-Chek SmartGuide CGM with the mySugr app.

Medtronic (NYSE:MDT) today shared real-world evidence highlighting improvements with its MiniMed 780G automated insulin ...

Insulet (Nasdaq:PODD) announced today that it appointed Flavia Pease to succeed Ana Maria Chadwick as EVP and CFO.

BD (NYSE:BDX) announced that it expanded its Class I voluntary recall for its Alaris Pump Module model 8100 infusion system.

Dexcom (Nasdaq:DXCM) today announced plans to unveil its Smart Basal integrated titration module for insulin delivery.

The FDA identified a recall of smartphone apps for Dexcom (Nasdaq:DXCM) continuous glucose monitors as the most serious type.

Teleflex (NYSE: TFX) announced today that it enrolled the first patient in its DUBSTENT DIABETES drug-eluting device trial.

Insulet (Nasdaq:PODD) has its eyes on future expansion in new geographies, according to some of its leading executives.

Elutia announced today that it agreed to sell its bioenvelope technologies to Boston Scientific for $88 million.

Dexcom (Nasdaq:DXCM) filed with the state of California to confirm plans to lay off more than 300 employees in San Diego.